- Efficacy of urine loss ratio for prognosis of urinary continence after radical prostatectomy: A retrospective cohort study in a single Japanese institution
-
Watari S, Ichikawa T, Shiraishi H, Tokunaga M, Kubota R, Kusumi N, Tsushima T
- KMID: 2540064
- Investig Clin Urol.
- 2023 Mar;64(2):168-174.
- doi: 10.4111/icu.20220380
Purpose: The usefulness of the urine loss ratio in the early postoperative period for prognosis of long-term urinary continence after radical prostatectomy has not been fully determined. Materials and Methods: All... -
- CITED
-
- Close
- SHARE
-
- Close
- Trends of stratified prostate cancer risk in a single Korean province from 2003 to 2021: A multicenter study conducted using regional training hospital data
-
Ko YH, Kim BH, Kwon SY, Jung HJ, Hah YS, Kim YJ, Kim HT, Lee JN, Kim JH, Kim TH, oboDKUOSG
- KMID: 2540060
- Investig Clin Urol.
- 2023 Mar;64(2):140-147.
- doi: 10.4111/icu.20220317
Purpose: To identify changes in prostate cancer (PCa) risk-stratification during the last two decades in Korea, where the social perception of PCa was limited due to a relatively low incidence... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness of Adding Docetaxel to Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer in Korean Real-World Practice
-
Park K, Kim JY, Park I, Shin SH, Lee HJ, Lee JL
- KMID: 2538957
- Yonsei Med J.
- 2023 Feb;64(2):86-93.
- doi: 10.3349/ymj.2022.0244
Purpose: Evidence in favor of adding docetaxel in treatment of metastatic hormone-sensitive prostate cancer (mHSPC) has led to docetaxel in conjunction with androgen deprivation therapy (ADT) as standard therapy. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Testosterone Recovery after Androgen Deprivation Therapy in Prostate Cancer: Building a Predictive Model
-
Borque-Fernando , Estrada-Domínguez F, Esteban LM, Gil-Sanz MJ, Sanz G
- KMID: 2537125
- World J Mens Health.
- 2023 Jan;41(1):129-141.
- doi: 10.5534/wjmh.210178
Purpose: To analyze the variability, associated actors, and the design of nomograms for individualized testosterone recovery after cessation of androgen deprivation therapy (ADT). Materials and Methods: A longitudinal study was carried... -
- CITED
-
- Close
- SHARE
-
- Close
- Human Endogenous Retroviruses: Friends and Foes in Urology Clinics
-
Lee SK, Kim SH, Ahnn J
- KMID: 2537304
- Int Neurourol J.
- 2022 Dec;26(4):275-287.
- doi: 10.5213/inj.2244284.142
Human endogenous retroviruses (HERVs) are originated from ancient exogenous retroviruses, which infected human germ line cells millions of years ago. HERVs have generally lost their replication and retrotransposition abilities, but... -
- CITED
-
- Close
- SHARE
-
- Close
- Animal Models for Bone Metastatic Prostate Cancer
-
Jeon WH, Song C, Jang SJ, Maeng S, Chang IH, Tae JH
- KMID: 2536653
- Korean J Urol Oncol.
- 2022 Nov;20(4):248-256.
- doi: 10.22465/kjuo.2022.20.4.248
Metastatic disease is a main cause of mortality in prostate cancer and remains to be uncurable despite emerging new treatment agents. Development of novel treatment agents are confined within the... -
- CITED
-
- Close
- SHARE
-
- Close
- An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
-
Hong JH
- KMID: 2536650
- Korean J Urol Oncol.
- 2022 Nov;20(4):207-222.
- doi: 10.22465/kjuo.2022.20.4.207
Theranostics is a new term which involves the integration of therapy and diagnosis in a single platform. Prostate-specific membrane antigen (PSMA) has emerged to be a novel promising target for... -
- CITED
-
- Close
- SHARE
-
- Close
- How can we best manage biochemical failure after radical prostatectomy?
-
Kim WT, Kim J, Kim WJ
- KMID: 2534614
- Investig Clin Urol.
- 2022 Nov;63(6):592-601.
- doi: 10.4111/icu.20220294
Biochemical recurrence (BCR) is common after radical prostatectomy, but effective treatment options for men with BCR after curative treatment remain controversial. Although prostate-specific antigen is widely used as a surrogate... -
- CITED
-
- Close
- SHARE
-
- Close
- Optimal Definition of Biochemical Recurrence in Patients Who Receive Salvage Radiotherapy Following Radical Prostatectomy for Prostate Cancer
-
Lee SU, Kim JS, Kim YS, Cho J, Choi SH, Nam TK, Jeong SM, Kim Y, Choi Y, Lee DE, Park W, Cho KH
- KMID: 2534198
- Cancer Res Treat.
- 2022 Oct;54(4):1191-1199.
- doi: 10.4143/crt.2021.985
Purpose This study proposed the optimal definition of biochemical recurrence (BCR) after salvage radiotherapy (SRT) following radical prostatectomy for prostate cancer. Materials and Methods Among 1,117 patients who had received SRT,... -
- CITED
-
- Close
- SHARE
-
- Close
- Silibinin Radiosensitizes EGF Receptor-knockdown Prostate Cancer Cells by Attenuating DNA Repair Pathways
-
Rajput M, Mishra D, Kumar K, Singh RP
- KMID: 2533966
- J Cancer Prev.
- 2022 Sep;27(3):170-181.
- doi: 10.15430/JCP.2022.27.3.170
Emergence of radioresistance in prostate cancer (PCa) cells is a major obstacle in cancer therapy and contributes to the relapse of the disease. EGF receptor (EGFR) signaling plays an important... -
- CITED
-
- Close
- SHARE
-
- Close
- Changes in prostate-specific antigen kinetics during androgen-deprivation therapy as a predictor of response to abiraterone in chemonaïve patients with metastatic castration-resistant prostate cancer
-
Lee CL, Chang YH, Liu CY, Hsieh ML, Huang LK, Chu YC, Kan HC, Lin PH, Yu KJ, Chuang CK, Wu CT, Pang ST, Shao IH
- KMID: 2532888
- Investig Clin Urol.
- 2022 Sep;63(5):546-553.
- doi: 10.4111/icu.20210450
Purpose: Metastatic castration-resistant prostate cancer (mCRPC) has a poor prognosis. Abiraterone acetate (AA), enzalutamide, and chemotherapy are first-line treatments for patients with mCRPC. This study examined prognostic factors for AA... -
- CITED
-
- Close
- SHARE
-
- Close
- Low serum total testosterone level as a predictor of upgrading in low-risk prostate cancer patients after radical prostatectomy: A systematic review and meta-analysis
-
Gan S, Liu J, Chen Z, Xiang S, Gu C, Li S, Wang S
- KMID: 2530909
- Investig Clin Urol.
- 2022 Jul;63(4):407-414.
- doi: 10.4111/icu.20210459
Purpose: To investigated the association between serum total testosterone and Gleason score upgrading of low-risk prostate cancer after radical prostatectomy (RP). Materials and Methods: Medline, Web of Science, Embase, and Cochrane... -
- CITED
-
- Close
- SHARE
-
- Close
- Androgen Deprivation Therapy in Patients with Prostate Cancer is Associated with the Risk of Subsequent Alzheimer’s Disease but Not with Vascular Dementia
-
Kim JW, Kim DK, Lee HS, Park JY, Ahn HK, Ha JS, Lee D, Cho KS
- KMID: 2530715
- World J Mens Health.
- 2022 Jul;40(3):481-489.
- doi: 10.5534/wjmh.210019
Purpose: We aimed to investigate the association between androgen deprivation therapy (ADT) and the risk of dementia according to subtypes of dementia in men with prostate cancer. Materials and Methods: We... -
- CITED
-
- Close
- SHARE
-
- Close
- Estimation of Utility Weights for Prostate-related Health States in Korea
-
Kim SH, Ock M, Jo MW, Park S
- KMID: 2530237
- J Prev Med Public Health.
- 2022 May;55(3):243-252.
- doi: 10.3961/jpmph.21.426
Objectives: Very limited previous research has investigated the utility weights of prostate-related diseases in the general population in Korea. The purpose of this study was to calculate the utility of... -
- CITED
-
- Close
- SHARE
-
- Close
- Germline pathogenic variants in unselected Korean men with prostate cancer
-
So MK, Ahn HK, Huh J, Kim KH
- KMID: 2529349
- Investig Clin Urol.
- 2022 May;63(3):294-300.
- doi: 10.4111/icu.20220044
Purpose: Prostate cancer is one of the most heritable cancers and prostate cancer with germline mutations is associated with aggressive features and a poor prognosis. We investigated germline variants in... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnostic accuracy of prostate-specific antigen below 4 ng/mL as a cutoff for diagnosing prostate cancer in a hospital setting: A systematic review and meta-analysis
-
Jin Y, Jung JH, Han WK, Hwang EC, Nho Y, Lee N, Yun JE, Lee KS, Lee SH, Lee H, Yu SY
- KMID: 2529343
- Investig Clin Urol.
- 2022 May;63(3):251-261.
- doi: 10.4111/icu.20210429
Purpose: A prostate-specific antigen (PSA) cutoff of 4 ng/mL has been widely used for prostate cancer screening in populationbased settings. However, the accuracy of PSA below 4 ng/mL as a... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Sedation Anesthesia With Intravenous Propofol on Transrectal Ultrasound-Guided Prostate Biopsy Outcomes
-
Kim HY, Choi YH, Lee SJ
- KMID: 2528173
- J Korean Med Sci.
- 2022 Apr;37(15):e115.
- doi: 10.3346/jkms.2022.37.e115
Background: Sedation anesthesia during transrectal ultrasound (TRUS)-guided prostate biopsy is known to decrease patient pain and anxiety, but little is known whether it affects the procedure’s prostate cancer detection and... -
- CITED
-
- Close
- SHARE
-
- Close
- Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zone
-
Kang HW, Byun YJ, Moon SM, Kim K, Piao XM, Zheng CM, Moon SK, Choi YH, Kim WT, Kim YJ, Lee SC, Yun SJ, Kim WJ
- KMID: 2526896
- Investig Clin Urol.
- 2022 Mar;63(2):238-244.
- doi: 10.4111/icu.20210493
Purpose: Tumor microRNAs (miRNAs) are released to biofluids directly or indirectly. Although urinary miRNAs are promising noninvasive biomarkers for the diagnosis of prostate cancer (PCa), their clinical application is challenging... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence and risk factors for incidental prostate cancer in patients after transurethral resection of the prostate with negative results on prostate biopsy: A retrospective study
-
Guo Z, He J, Pan J, Huang L, Cao J, Bai Z, Wang S, Xiang S, Gu C, Wang Z
- KMID: 2526899
- Investig Clin Urol.
- 2022 Mar;63(2):201-206.
- doi: 10.4111/icu.20210415
Purpose: This study aimed to explore the prevalence and predictors of incidental prostate cancer (IPC) after transurethral resection of the prostate (TURP) with negative results on transperineal magnetic resonance imaging... -
- CITED
-
- Close
- SHARE
-
- Close
- Sleep Disturbance in Patients with Prostate Cancer: A Scoping Review
-
Baek S, Park S, Kim H, Kim SH, Kim S
- KMID: 2526692
- Korean J Adult Nurs.
- 2022 Feb;34(1):1-14.
- doi: 10.7475/kjan.2022.34.1.1
Purpose Patients with prostate cancer have high survival rates, but report low Quality of Life (QOL) due to sleep difficulties. This scoping review aimed to explore and identify current publication trends,... -
- CITED
-
- Close
- SHARE
-
- Close
